Synergistic Effect Between Lipoprotein Lipase and Apolipoprotein C3 Genes in Determining the Severity of Coronary Artery Disease

Overview

Journal J Cardiovasc Transl Res

Publisher Springer

Specialty Cardiology & Vascular Diseases

Date 2013 Feb 5

PMID 23377670

Citations 2

Authors

Tarek A Abd-El-Aziz

Randa H Mohamed

Amal S El-Shal

Affiliations

Soon will be listed here.

Abstract

A number of genetic variants have been identified in the lipoprotein lipase (LPL) gene. We aimed to investigate the possible associations between LPL gene and apolipoprotein C3 (APOC3) gene polymorphisms with coronary artery disease (CAD) and its severity, as well as the interaction between these polymorphisms and classical risk factors. The HindIII variant of LPL and APOC3 were genotyped in 156 CAD patients and 154 subjects as a control group. We found that the odds ratio (OR) estimating the effect of joint exposure to H2H2 genotype of LPL and S2S2 genotype of APOC3 was significantly higher than the OR estimating the effect of each factor in the absence of the other. The present study points to a synergistic interaction between H2H2 genotype of LPL gene and S2S2 genotype of APOC3 gene that leads to increased severity of CAD. Smoking, low HDL, and diabetes increased the severity of CAD in patients carrying these risky genotypes.

Citing Articles

Associations between gene polymorphisms and coronary artery disease: evidence based on an updated and cumulative meta-analysis.

Ma W, Wang Y, Han X, Zhu Y, Liu N Biosci Rep. 2018; .

PMID: 29459423 PMC: 5857905. DOI: 10.1042/BSR20171642.

Association between Apolipoprotein C-III Gene Polymorphisms and Coronary Heart Disease: A Meta-analysis.

Zhang J, Xie X, Ma Y, Zheng Y, Yang Y, Li X Aging Dis. 2016; 7(1):36-44.

PMID: 26816662 PMC: 4723232. DOI: 10.14336/AD.2015.0709.

References

Gotoda T, Yamada N, Murase T, Shimano H, Shimada M, Harada K . Detection of three separate DNA polymorphisms in the human lipoprotein lipase gene by gene amplification and restriction endonuclease digestion. J Lipid Res. 1992; 33(7):1067-72. View

Rothman K . Synergy and antagonism in cause-effect relationships. Am J Epidemiol. 1974; 99(6):385-8. DOI: 10.1093/oxfordjournals.aje.a121626. View

Clee S, Bissada N, Miao F, Miao L, Marais A, Henderson H . Plasma and vessel wall lipoprotein lipase have different roles in atherosclerosis. J Lipid Res. 2000; 41(4):521-31. View

Bobik A . Apolipoprotein CIII and atherosclerosis: beyond effects on lipid metabolism. Circulation. 2008; 118(7):702-4. DOI: 10.1161/CIRCULATIONAHA.108.794081. View

Hoffer M, Sijbrands E, de Man F, Havekes L, Smelt A, Frants R . Increased risk for endogenous hypertriglyceridaemia is associated with an apolipoprotein C3 haplotype specified by the SstI polymorphism. Eur J Clin Invest. 1998; 28(10):807-12. DOI: 10.1046/j.1365-2362.1998.00361.x. View

Alaupovic P . Significance of apolipoproteins for structure, function, and classification of plasma lipoproteins. Methods Enzymol. 1996; 263:32-60. DOI: 10.1016/s0076-6879(96)63004-3. View

Bainton D, MILLER N, Bolton C, Yarnell J, Sweetnam P, Baker I . Plasma triglyceride and high density lipoprotein cholesterol as predictors of ischaemic heart disease in British men. The Caerphilly and Speedwell Collaborative Heart Disease Studies. Br Heart J. 1992; 68(1):60-6. PMC: 1024973. DOI: 10.1136/hrt.68.7.60. View

Goldberg I . Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res. 1996; 37(4):693-707. View

Kawakami A, Aikawa M, Libby P, Alcaide P, Luscinskas F, Sacks F . Apolipoprotein CIII in apolipoprotein B lipoproteins enhances the adhesion of human monocytic cells to endothelial cells. Circulation. 2006; 113(5):691-700. DOI: 10.1161/CIRCULATIONAHA.105.591743. View

10.

Pasalic D, Ferencak G, Grskovic B, Sesto M, Stavljenic-Rukavina A . Association of two genetic variations of lipoprotein lipase, S447X and Hind III, with coronary artery disease and hypertriglyceridemia. Coll Antropol. 2006; 30(3):549-54. View

11.

Wolk R, Berger P, Lennon R, Brilakis E, Johnson B, Somers V . Plasma leptin and prognosis in patients with established coronary atherosclerosis. J Am Coll Cardiol. 2004; 44(9):1819-24. DOI: 10.1016/j.jacc.2004.07.050. View

12.

Magill P, Rao S, MILLER N, Nicoll A, Brunzell J, St Hilaire J . Relationships between the metabolism of high-density and very-low-density lipoproteins in man: studies of apolipoprotein kinetics and adipose tissue lipoprotein lipase activity. Eur J Clin Invest. 1982; 12(2):113-20. DOI: 10.1111/j.1365-2362.1982.tb00947.x. View

13.

McConathy W, Gesquiere J, Bass H, Tartar A, Fruchart J, Wang C . Inhibition of lipoprotein lipase activity by synthetic peptides of apolipoprotein C-III. J Lipid Res. 1992; 33(7):995-1003. View

14.

Vlietstra R, Kronmal R, Frye R, Seth A, Tristani F, KILLIP 3rd T . Factors affecting the extent and severity of coronary artery disease in patients enrolled in the coronary artery surgery study. Arteriosclerosis. 1982; 2(3):208-15. DOI: 10.1161/01.atv.2.3.208. View

15.

Wittrup H, Tybjaerg-Hansen A, Nordestgaard B . Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis. Circulation. 1999; 99(22):2901-7. DOI: 10.1161/01.cir.99.22.2901. View

16.

Russo G, Meigs J, Cupples L, Demissie S, Otvos J, Wilson P . Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study. Atherosclerosis. 2001; 158(1):173-81. DOI: 10.1016/s0021-9150(01)00409-9. View

17.

FRIEDEWALD W, Levy R, Fredrickson D . Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18(6):499-502. View

18.

Freeman D, Caslake M, Griffin B, Hinnie J, Tan C, Watson T . The effect of smoking on post-heparin lipoprotein and hepatic lipase, cholesteryl ester transfer protein and lecithin:cholesterol acyl transferase activities in human plasma. Eur J Clin Invest. 1998; 28(7):584-91. DOI: 10.1046/j.1365-2362.1998.00328.x. View

19.

Murthy V, Julien P, Gagne C . Molecular pathobiology of the human lipoprotein lipase gene. Pharmacol Ther. 1996; 70(2):101-35. DOI: 10.1016/0163-7258(96)00005-8. View

20.

Abd El-Aziz T, Mohamed R, Hashem R . Association of lipoprotein lipase and apolipoprotein C-III genes polymorphism with acute myocardial infarction in diabetic patients. Mol Cell Biochem. 2011; 354(1-2):141-50. DOI: 10.1007/s11010-011-0813-6. View